These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18317953)

  • 21. Genetics of pituitary adenomas.
    Gadelha MR; Trivellin G; Hernández Ramírez LC; Korbonits M
    Front Horm Res; 2013; 41():111-40. PubMed ID: 23652674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetics of familial pituitary adenomas].
    Beckers A; Jaffrain-Rea ML; Daly AE
    Bull Acad Natl Med; 2009 Oct; 193(7):1557-70; discussion 1570-1. PubMed ID: 20669636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
    Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
    Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial pituitary adenomas with a heterogeneous functional pattern: clinical and genetic features.
    Raverot G; Arnous W; Calender A; Trouillas J; Sassolas G; Bournaud C; Pugeat M; Borson-Chazot F
    J Endocrinol Invest; 2007 Oct; 30(9):787-90. PubMed ID: 17993773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of secretory granules of silent pituitary adenomas.
    Holck S; Wewer UM; Albrechtsen R
    Mod Pathol; 1988 May; 1(3):212-5. PubMed ID: 3237702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and genetic features of familial pituitary adenomas.
    Daly AF; Jaffrain-Rea ML; Beckers A
    Horm Metab Res; 2005 Jun; 37(6):347-54. PubMed ID: 16001326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.
    Daly AF; Tichomirowa MA; Petrossians P; Heliövaara E; Jaffrain-Rea ML; Barlier A; Naves LA; Ebeling T; Karhu A; Raappana A; Cazabat L; De Menis E; Montañana CF; Raverot G; Weil RJ; Sane T; Maiter D; Neggers S; Yaneva M; Tabarin A; Verrua E; Eloranta E; Murat A; Vierimaa O; Salmela PI; Emy P; Toledo RA; Sabaté MI; Villa C; Popelier M; Salvatori R; Jennings J; Longás AF; Labarta Aizpún JI; Georgitsi M; Paschke R; Ronchi C; Valimaki M; Saloranta C; De Herder W; Cozzi R; Guitelman M; Magri F; Lagonigro MS; Halaby G; Corman V; Hagelstein MT; Vanbellinghen JF; Barra GB; Gimenez-Roqueplo AP; Cameron FJ; Borson-Chazot F; Holdaway I; Toledo SP; Stalla GK; Spada A; Zacharieva S; Bertherat J; Brue T; Bours V; Chanson P; Aaltonen LA; Beckers A
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E373-83. PubMed ID: 20685857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms.
    Inomoto C; Tahara S; Oyama K; Kimura M; Matsuno A; Teramoto A; Osamura RY
    Brain Tumor Pathol; 2021 Jul; 38(3):183-188. PubMed ID: 34269950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.
    Tanaka C; Yoshimoto K; Yamada S; Nishioka H; Ii S; Moritani M; Yamaoka T; Itakura M
    J Clin Endocrinol Metab; 1998 Mar; 83(3):960-5. PubMed ID: 9506756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary tumors in patients with MEN1 syndrome.
    Syro LV; Scheithauer BW; Kovacs K; Toledo RA; Londoño FJ; Ortiz LD; Rotondo F; Horvath E; Uribe H
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):43-8. PubMed ID: 22584705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of the 2017 WHO Classification of Pituitary Tumors.
    Mete O; Lopes MB
    Endocr Pathol; 2017 Sep; 28(3):228-243. PubMed ID: 28766057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial pituitary adenomas.
    Tichomirowa MA; Daly AF; Beckers A
    J Intern Med; 2009 Jul; 266(1):5-18. PubMed ID: 19522822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.
    McDonald WC; McDonald KN; Helmer JA; Ho B; Wang A; Banerji N
    Arch Pathol Lab Med; 2021 May; 145(5):592-598. PubMed ID: 32991684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACTH and alpha-subunit are co-expressed in rare human pituitary corticotroph cell adenomas proposed to originate from ACTH-committed early pituitary progenitor cells.
    Suzuki M; Egashira N; Kajiya H; Minematsu T; Takekoshi S; Tahara S; Sanno N; Teramoto A; Osamura RY
    Endocr Pathol; 2008; 19(1):17-26. PubMed ID: 18228160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
    Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
    J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.
    Cooper O; Ben-Shlomo A; Bonert V; Bannykh S; Mirocha J; Melmed S
    Horm Cancer; 2010 Apr; 1(2):80-92. PubMed ID: 20717480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pituitary pathology and MEN 1].
    Betea D; Valdes Socin H; Beckers A
    Ann Endocrinol (Paris); 2000 Sep; 61(3):214-23. PubMed ID: 10970947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of additional transcription factors is of prognostic value for aggressive behavior of pituitary adenomas.
    Micko A; Rötzer T; Hoftberger R; Vila G; Oberndorfer J; Frischer JM; Knosp E; Wolfsberger S
    J Neurosurg; 2021 Mar; 134(3):1139-1146. PubMed ID: 32302984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
    Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
    Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.
    Stratakis CA; Schussheim DH; Freedman SM; Keil MF; Pack SD; Agarwal SK; Skarulis MC; Weil RJ; Lubensky IA; Zhuang Z; Oldfield EH; Marx SJ
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4776-80. PubMed ID: 11134142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.